You are here: Industry Insights > CRISPR-Cas9

News List

Merck Granted US Patents for Foundational CRISPR-Cas9 Technology expresspharma
May 12, 2020
CRISPR technology is a core competency for Merck, which has 16 years’ experience with genome editing, spanning discovery to manufacturing.
Gene-edited Babies Immune to HIV: A Discussion about “CRISPR-Cas9” and “CCR5” 1℃
December 05, 2018
This is the world’s first case of gene-edited babies immune to HIV, and shows a historic breakthrough of China in the field of genome editing technique for disease prevention.”
Researcher defends use of gene-editing technology to alter embryos as criticism mounts firstwordpharma
November 28, 2018
A researcher who has been met with widespread criticism after claiming to have used CRISPR-Cas9 gene-editing technology to alter the embryonic genes of twin girls born earlier this month in China defended the work on Wednesday.
CRISPR biotech Editas to lose CMO as it continues push for clinical trials fiercebiotech
August 29, 2018
Editas is now looking for a new CMO as it also plots its first clinical trials
MPEG LA invites CRISPR-Cas9 patents to be pooled in a one-stop license biospectrumasia
May 03, 2017
Accessibility to a multi-user market will maximize CRISPR’s life-enhancing potential